Bank of New York Mellon’s GT Biopharma GTBP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-3,175
| Closed | -$24.3K | – | 4218 |
|
|
2023
Q4 | $24.3K | Hold |
3,175
| – | – | ﹤0.01% | 4215 |
|
|
2023
Q3 | $23K | Hold |
3,175
| – | – | ﹤0.01% | 4233 |
|
|
2023
Q2 | $29.7K | Hold |
3,175
| – | – | ﹤0.01% | 4233 |
|
|
2023
Q1 | $52.4K | Hold |
3,175
| – | – | ﹤0.01% | 4185 |
|
|
2022
Q4 | $84.4K | Hold |
3,175
| – | – | ﹤0.01% | 4146 |
|
|
2022
Q3 | $167K | Sell |
3,175
-114
| -3% | -$6K | ﹤0.01% | 4078 |
|
|
2022
Q2 | $294K | Sell |
3,289
-1,446
| -31% | -$129K | ﹤0.01% | 3889 |
|
|
2022
Q1 | $409K | Sell |
4,735
-102
| -2% | -$8.81K | ﹤0.01% | 3830 |
|
|
2021
Q4 | $441K | Buy |
4,837
+265
| +6% | +$24.2K | ﹤0.01% | 3881 |
|
|
2021
Q3 | $925K | Buy |
4,572
+2,615
| +134% | +$529K | ﹤0.01% | 3432 |
|
|
2021
Q2 | $910K | Buy |
+1,957
| New | +$910K | ﹤0.01% | 3478 |
|